American Portfolios Advisors’s United Therapeutics UTHR Stock Holding History

American Portfolios Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$17.4K	Buy	83 +75	+938%	+$16.8K	﹤0.01%	2258
2022 Q2	$1.89K	Hold	8	–	–	﹤0.01%	3146
2022 Q1	$1.44K	Hold	8	–	–	﹤0.01%	3297
2021 Q4	$1.73K	Hold	8	–	–	﹤0.01%	3210
2021 Q3	$1.48K	Hold	8	–	–	﹤0.01%	3225
2021 Q2	$1.44K	Sell	8 -2	-20%	-$381	﹤0.01%	3201
2021 Q1	$1.67K	Buy	+10	New	+$1.67K	﹤0.01%	3030
2020 Q1	–	Sell	-50	Closed	-$4.4K	–	2921
2019 Q4	$4.4K	Hold	50	–	–	﹤0.01%	2333
2019 Q3	$3.99K	Hold	50	–	–	﹤0.01%	2269
2019 Q2	$3.9K	Hold	50	–	–	﹤0.01%	2267
2019 Q1	$5.87K	Hold	50	–	–	﹤0.01%	2032
2018 Q4	$5.45K	Hold	50	–	–	﹤0.01%	1846
2018 Q3	$6.39K	Hold	50	–	–	﹤0.01%	1918
2018 Q2	$5.66K	Hold	50	–	–	﹤0.01%	1938
2018 Q1	$5.62K	Hold	50	–	–	﹤0.01%	1846
2017 Q4	$7.4K	Buy	+50	New	+$6.36K	﹤0.01%	1673

Other funds holding UTHR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

American Portfolios Advisors's UTHR Position: Q3 2022 in Review

American Portfolios Advisors increased its United Therapeutics (UTHR) stake by 938% in Q3 2022, buying an estimated $16.8K and bringing the position to 83 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2258.

American Portfolios Advisors first reported a position in UTHR in Q4 2017 and has held it in 16 quarters since. 461 funds tracked by Wall St. Rank hold UTHR as of Q3 2022.

American Portfolios Advisors held 83 shares of United Therapeutics worth $17.4K as of Q3 2022.
American Portfolios Advisors bought 75 United Therapeutics shares in Q3 2022, an estimated $16.8K.
United Therapeutics made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2258 holding.
American Portfolios Advisors first reported a position in United Therapeutics in Q4 2017 and has held it in 16 quarters since.
461 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.